Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-24 @ 4:44 PM
NCT ID:
NCT04353466
Eligibility Criteria:
Inclusion Criteria:
* GD patients, male and female, 18 years or older
* Currently treated with enzyme replacement therapy for 5 years and more, with a stable unchanged dose in the previous 6 months
* Imaging features of significant residual bone disease defined as QCSI under 0.3 bone at risk
* Able to provide written informed consent
Exclusion Criteria:
* Currently taking another experimental drug for any condition
* Presence of any medical, emotional, behavioral or psychological condition that in the judgment of the Investigator would interfere with the patient's compliance with the requirements of the study.
* Past exposure to Elelyso
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04353466
Study Brief:
Protocol Section:
NCT04353466